Janux Therapeutics

1 follower


Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.

Industries

Employees

51-200

Links

Org chart

Hiring!

David Campbell
President & CEO

David Campbell

Collapse
Tighe Reardon
Acting CFO
Andy Meyer
Chief Business Officer
Byron Robinson
Chief Strategy Officer
Carolina Caffaro
Executive Director, CMC
Hans Aerni
Senior Director, CMC Analytical Development
Jerry Warren
Senior Director Regulatory Affairs
Lina Ma
Associate Director in Pharmacology
Natalija Van Braeckel Budimir
Director, Immunology
Nick Almaguer
Director, Analytical Development
Sara Walsh
Executive Administrative Assistant to the President and Chief Executive Officer
Sheila Gujrathi, MD
Director Board Of Directors
Yogesh Bramhecha, PhD
Director, Biomarker Discovery
James Pennington
General Counsel
Zachariah McIver
Vice President at Janux Therapeutics
Tommy DiRaimondo
Executive Director, Research & Development
Megan Shannon
Senior Director, Clinical Science